摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-β-hydroxyethylthioethylamine hydrochloride

中文名称
——
中文别名
——
英文名称
2-β-hydroxyethylthioethylamine hydrochloride
英文别名
2-(Ethylaminosulfanyl)ethanol;hydrochloride;2-(ethylaminosulfanyl)ethanol;hydrochloride
2-β-hydroxyethylthioethylamine hydrochloride化学式
CAS
——
化学式
C4H11NOS*ClH
mdl
——
分子量
157.664
InChiKey
GRMKIHOMEDHWEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.66
  • 重原子数:
    8
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    57.6
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    Oral treatment of seborrhea with cysteamine derivatives
    摘要:
    一种治疗头皮过度分泌皮脂的方法,通过减少该过度分泌来改善头皮状况,包括口服给予头皮有过度分泌特征的人类的治疗组合物,该组合物包括与可摄入载体混合的,作为无毒活性化合物的半胱氨酸或半胱胺衍生物,活性化合物的含量约为组合物的0.75-3重量百分比,根据人类体重以每天1-5毫克/千克的速率给予,治疗期约为15天。
    公开号:
    US04035492A1
点击查看最新优质反应信息

文献信息

  • Process and cosmetic compositions for the treatment of skin and scalp
    申请人:L'Oreal
    公开号:US03976781A1
    公开(公告)日:1976-08-24
    A method, composition and compounds useful in said compositions for treating the skin and scalp characterized by an excessive secretion of sebum to improve the condition thereof by reducing said excessive secretion of sebum includes topically applying to a human having skin and/or a scalp so characterized a cosmetic composition containing as an active ingredient a derivative of cysteine or cysteamine. The composition contains about 0.1-5 weight percent of said derivative and also contains as a carrier for the active ingredient, water, a mixture of water and a lower alkanol, a lower alkanol, a mixture of a lower alkanol and a cosmetic resin, a reducing agent, a neutralizing agent or a vegetable oil.
    一种用于治疗皮肤和头皮的方法、组合物和化合物,其特点是皮脂分泌过多,通过减少该过多的皮脂分泌改善其状况。包括将含有半胱氨酸或半胱胺衍生物作为活性成分的化妆品组合物局部涂抹于皮肤和/或头皮皮肤分泌过多的人体上。该组合物含有约0.1-5重量百分比的该衍生物,并且还含有作为活性成分载体的水、水和低级烷醇的混合物、低级烷醇、低级烷醇和化妆树脂的混合物、还原剂、中和剂或植物油。
  • Oral treatment of seborrhea with cysteamine derivatives
    申请人:L'Oreal
    公开号:US04035492A1
    公开(公告)日:1977-07-12
    A method for treating a scalp characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with, as a non-toxic active compound, cysteine or cysteamine derivatives, the active compound is present in amounts of about 0.75-3 weight percent of the composition which is administered at a rate of about 1-5 mg/kg/day based on the weight of the human being during a period of about 15 days.
    一种治疗头皮过度分泌皮脂的方法,通过减少该过度分泌来改善头皮状况,包括口服给予头皮有过度分泌特征的人类的治疗组合物,该组合物包括与可摄入载体混合的,作为无毒活性化合物的半胱氨酸或半胱胺衍生物,活性化合物的含量约为组合物的0.75-3重量百分比,根据人类体重以每天1-5毫克/千克的速率给予,治疗期约为15天。
查看更多

同类化合物

甲磺酸 N,N-二甲基-2,2-二甲基乙烷次磺酰胺 2-甲基异噻唑烷 2-氰基-2-五氟苯基丁酸乙酯 N-methyl-N-tert.-octylthiomethylamine hydrochloride N-methyl-N-ethylthiomethylamine hydrochloride N-methyl-N-isopropylthiomethylamine hydrochloride perfluoro-2-methyl-1-cyclopenten-N,N-diethylsulfenamide 2-β-hydroxyethylthioethylamine hydrochloride 2-Amino-aethan-1-sulfensaeure N,N'-bis(1,1,1,2,3,3,3-heptafluoropropan-2-ylsulfanyl)-N,N'-dimethylethane-1,2-diamine N-[(1,1,2,2-Tetrachloroethyl)sulfanyl]methanamine 2-methyl-3,6-dihydro-1,2-thiazine N,N-dibutyl-hexane-1-sulfenamide N-[2-(dimethylaminosulfanyl)ethylsulfanyl]-N-methylmethanamine N-(butylthio)-tert-butylamine 1,1-dimethyl-ethanesulfenic acid dibutylamide N-Methylmethansulfenamid N-(tert-butylthio)ethylamine N-(tert-butylthio)butylamine N-(tert-butylthio)cyclohexylamine N,N-Dimethyl-2-chlortetrafluoraethansulfenamid N-<2-(Methlthio)-ethylthio>-dimethylamin N,N-Di-n-butylmethansulphenamid nonafluoro-n-butanesulfenic acid N-(Chlormethylthio)diethylamin N-[2-[2-[ethyl(methyl)amino]sulfanylethoxy]ethylsulfanyl]-N-methylethanamine N-ethyl-N-methyl-hexanesulfenamide N-(tert-butylthio)methylamine 2-isopropyl-4,5-dimethyl-3,6-dihydro-1,2-thiazine N-(Chlormethylthio)dimethylamin N-[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]sulfanyl-N-methylmethanamine N-(Propan-2-yl)-N-(propylsulfanyl)propan-2-amine N-Ethyl-N-(propylsulfanyl)ethanamine N,N-dipropyl-propane-1-sulfenamide 2-methyl-N-(2-methylpropyl)-N-propylsulfanylpropan-1-amine N-Butylpropanesulfenamide N,N-diethylmethanesulfenamide 1-Chlor-N-(1,1,3,3-tetramethylbutyl)-1,1-bis(trifluormethyl)methansulfenamid N-(1-Adamantyl)-1-chlor-1,1-bis(trifluormethyl)methansulfenamid N-(tert-butylthio)isopropylamine 4-Propyl-1,3,4-oxathiazinane (5Z)-3-(methylsulfanylamino)-5-[(Z)-prop-1-enyl]nona-1,5-dien-2-olate N-ethyl-N-ethylsulfanyl-2-(methylideneamino)ethenamine 4,4-Dichloro-3-octylidene-1,2-thiazolidine N,2-dimethyl-N-methylsulfanylpentan-1-amine (1R,2R)-1,2-bis(hydroxysulfanyl)ethane-1,2-diol 2-(Methylaminosulfanyl)ethanamine 2-Ethyl-3-hydroxysulfanylbutan-1-ol 2-ethyl-2-methyl-N-(5-methylhexyl)-N-methylsulfanylhexan-1-amine